Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland.
作者信息
Perez-Saez Javier, Lauer Stephen A, Kaiser Laurent, Regard Simon, Delaporte Elisabeth, Guessous Idris, Stringhini Silvia, Azman Andrew S
机构信息
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, MD, USA; Institute of Global Health, University of Geneva, Switzerland.
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, MD, USA.
出版信息
Lancet Infect Dis. 2021 Apr;21(4):e69-e70. doi: 10.1016/S1473-3099(20)30584-3. Epub 2020 Jul 14.
Abstract
摘要
相似文献
1
Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland.
Lancet Infect Dis. 2021 Apr;21(4):e69-e70. doi: 10.1016/S1473-3099(20)30584-3. Epub 2020 Jul 14.
2
Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis.
Lancet Infect Dis. 2021 Feb;21(2):203-212. doi: 10.1016/S1473-3099(20)30769-6. Epub 2020 Oct 19.
3
Estimating COVID-19 mortality in Italy early in the COVID-19 pandemic.
Nat Commun. 2021 May 12;12(1):2729. doi: 10.1038/s41467-021-22944-0.
4
Specchio-COVID19 cohort study: a longitudinal follow-up of SARS-CoV-2 serosurvey participants in the canton of Geneva, Switzerland.
BMJ Open. 2022 Jan 31;12(1):e055515. doi: 10.1136/bmjopen-2021-055515.
5
Viral load of SARS-CoV-2 across patients and compared to other respiratory viruses.
Microbes Infect. 2020 Nov-Dec;22(10):617-621. doi: 10.1016/j.micinf.2020.08.004. Epub 2020 Sep 7.
6
Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19).
Trials. 2021 Jan 4;22(1):1. doi: 10.1186/s13063-020-04976-x.
7
A scaling approach to estimate the age-dependent COVID-19 infection fatality ratio from incomplete data.
PLoS One. 2021 Feb 17;16(2):e0246831. doi: 10.1371/journal.pone.0246831. eCollection 2021.
8
A first analysis of excess mortality in Switzerland in 2020.
PLoS One. 2021 Jun 17;16(6):e0253505. doi: 10.1371/journal.pone.0253505. eCollection 2021.
9
Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.
Nat Commun. 2020 Nov 27;11(1):6044. doi: 10.1038/s41467-020-19943-y.
10
Delay-adjusted age- and sex-specific case fatality rates for COVID-19 in South Korea: Evolution in the estimated risk of mortality throughout the epidemic.
Int J Infect Dis. 2020 Dec;101:306-311. doi: 10.1016/j.ijid.2020.09.1478. Epub 2020 Oct 2.
引用本文的文献
1
Predicting SARS-CoV-2-specific CD4 and CD8 T-cell responses elicited by inactivated vaccines in healthy adults using machine learning models.
Clin Exp Med. 2025 Jul 8;25(1):236. doi: 10.1007/s10238-025-01772-2.
2
Improving case fatality ratio estimates in ongoing pandemics through case-to-death time distribution analysis.
Sci Rep. 2025 Feb 13;15(1):5402. doi: 10.1038/s41598-025-89441-y.
3
The real-time infection hospitalisation and fatality risk across the COVID-19 pandemic in England.
Nat Commun. 2024 May 31;15(1):4633. doi: 10.1038/s41467-024-47199-3.
4
Bayesian workflow for time-varying transmission in stratified compartmental infectious disease transmission models.
PLoS Comput Biol. 2024 Apr 29;20(4):e1011575. doi: 10.1371/journal.pcbi.1011575. eCollection 2024 Apr.
5
Estimates of early outbreak-specific SARS-CoV-2 epidemiological parameters from genomic data.
Proc Natl Acad Sci U S A. 2024 Jan 9;121(2):e2308125121. doi: 10.1073/pnas.2308125121. Epub 2024 Jan 4.
6
Psychological impact of COVID-19 and determinants among Spanish university students.
Front Public Health. 2023 Oct 18;11:1252849. doi: 10.3389/fpubh.2023.1252849. eCollection 2023.
7
Analysis of the prevalence of anti-SARS-CoV-2 antibodies in groups of medical and non-medical professions.
Int J Occup Med Environ Health. 2023 Nov 27;36(5):643-655. doi: 10.13075/ijomeh.1896.02162. Epub 2023 Sep 27.
8
Unique SARS-CoV-2 Variants, Tourism Metrics, and B.1.2 Emergence in Early COVID-19 Pandemic: A Correlation Analysis in South Dakota.
Int J Environ Res Public Health. 2023 Sep 13;20(18):6748. doi: 10.3390/ijerph20186748.
9
Age-specific severity of severe acute respiratory syndrome coronavirus 2 in February 2020 to June 2021 in the Netherlands.
Influenza Other Respir Viruses. 2023 Aug 22;17(8):e13174. doi: 10.1111/irv.13174. eCollection 2023 Aug.
10
Quantification of early nonpharmaceutical interventions aimed at slowing transmission of Coronavirus Disease 2019 in the Navajo Nation and surrounding states (Arizona, Colorado, New Mexico, and Utah).
PLOS Glob Public Health. 2023 Jun 21;3(6):e0001490. doi: 10.1371/journal.pgph.0001490. eCollection 2023.
本文引用的文献
1
A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates.
Int J Infect Dis. 2020 Dec;101:138-148. doi: 10.1016/j.ijid.2020.09.1464. Epub 2020 Sep 29.
2
Are Seroprevalence Estimates for Severe Acute Respiratory Syndrome Coronavirus 2 Biased?
J Infect Dis. 2020 Nov 9;222(11):1772-1775. doi: 10.1093/infdis/jiaa523.
3
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study.
Lancet. 2020 Aug 1;396(10247):313-319. doi: 10.1016/S0140-6736(20)31304-0. Epub 2020 Jun 11.
4
Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond Princess cruise ship, February 2020.
Euro Surveill. 2020 Mar;25(12). doi: 10.2807/1560-7917.ES.2020.25.12.2000256.
5
Early epidemiological assessment of the virulence of emerging infectious diseases: a case study of an influenza pandemic.
PLoS One. 2009 Aug 31;4(8):e6852. doi: 10.1371/journal.pone.0006852.
Zotero 插件